Answers are grounded in this paper and cite their sources.
OBJECTIVE: To describe the use of oral mycophenolate mofetil (MMF) as an adjunctive therapy in 2 cats with primary immune-mediated hemolytic anemia. CASE SERIES SUMMARY: Two cats suffering from presumptive primary immune mediated hemolytic were treated with MMF as part of their treatment regimens. Both cats had improved complete blood counts following therapy. NEW OR UNIQUE INFORMATION PROVIDED: This is the first reported use of oral MMF as adjunctive treatment for cats with immune-mediated hemolytic anemia. Outcome was favorable in both cats and no adverse effects were noted from the MMF.
No takes yet. Share an insight, caveat, or question.
Bacek et al. (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: